Orsulic S, Li Y, Soslow RA, Vitale-Cross LA, Gutkind SJ, Varmus HE.  Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell.  2002;1:53-62.  

Xing D, Orsulic S.  A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance. Proc Natl Acad Sci USA. 2005;102:6939-6941.  

Gasser S, Orsulic S, Brown E, Raulet D.  The DNA damage pathway regulates innate immune system ligands for the NKG2D receptor. Nature. 2005;436:1186-1190.

Xing D, Orsulic S.  A mouse model for the molecular characterization of BRCA1-associated ovarian carcinoma.  Cancer Research. 2006;18:8949-8953.

Miao J, Wang Z, Provencher H, Muir B, Dahiya S, Carney E, Leong C-O, Sgroi DC, Orsulic S.  HOXB13 induces ovarian cancer progression. Proc Natl Acad Sci USA. 2007;104:17093-17098. 

Xing D, Scangas G, Nita M, He L, Xu X, Ioffe Y, Aspuria P-J, Hedvat CY, Anderson ML, Oliva E, Karlan BY, Mohapatra G, Orsulic S.   A role for BRCA1 in uterine leiomyosarcoma. Cancer Research. 2009;69:8231-8235. 

Cancer Genome Atlas Research Network. ...Orsulic SIntegrated Genomic Analysis of Ovarian Cancer.  Nature. 2011;474:609-615.  

Selected Reviews and Book Chapters

Orsulic S.  Ovarian Cancer. In Mouse Models of Cancer , 1st Ed., John Wiley & Sons, New York, 2004.

Cheon D-J and Orsulic S.  Mouse Models of Cancer.  Annual Reviews of Pathology: Mechanisms of Disease. Volume 6, 2010.

For a list of Dr. Orsulic's publications, please click here

Lab in the Media

Advances in Cancer, Spring 2014

Time Warner Cable TV Interview with Brad Pomerance

Android app on Google Play